APA (7th ed.) Citation

M, R., M, D., R, S., K, K., R, H., A, E., . . . M, V. (2026). Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study. Clinical drug investigation, 46(7), 733. https://doi.org/10.1007/s40261-026-01561-z

Chicago Style (17th ed.) Citation

M, Rowe, Dinh M, Sherry R, Keefer K, Hazlitt R, Elghzali A, Archer D, Ford AI, and Vassar M. "Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study." Clinical Drug Investigation 46, no. 7 (2026): 733. https://doi.org/10.1007/s40261-026-01561-z.

MLA (9th ed.) Citation

M, Rowe, et al. "Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison Study." Clinical Drug Investigation, vol. 46, no. 7, 2026, p. 733, https://doi.org/10.1007/s40261-026-01561-z.